RISK MODIFICATION OF TUBERCULOSIS INFECTION BY CHEMOPROPHYLAXIS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TNF INHIBITORS: A NATION-WIDE COHORT STUDY

被引：0
|
作者：
Shin, A. [1 ]
Park, E. H. [1 ]
Ha, Y. J. [1 ]
Lee, Y. J. [1 ]
Song, Y. W. [2 ]
Kang, E. H. [1 ]
机构：
[1] Seoul Natl Univ Bundang Hosp, Seongnam, South Korea
[2] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
LATENT TUBERCULOSIS;
D O I：
10.1136/annrheumdis-2020-eular.2072
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0180
引用
收藏
页码：303 / 304
页数：2
相关论文
共 50 条
  • [1] THE COMPARATIVE RISK OF OSTEOPOROTIC FRACTURES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TNF INHIBITORS VERSUS OTHER BIOLOGICS: A NATION-WIDE COHORT STUDY IN KOREA
    Shin, Anna
    Dong, Yaa-Hui
    Shin, Seunghwan
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong Wook
    Kang, Eun Ha
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 726 - 726
  • [2] The Comparative Risk of Osteoporotic Fractures Among Patients with Rheumatoid Arthritis Receiving TNF Inhibitors versus Other Biologics: A Nation-wide Cohort Study in Korea
    Park, Eun Hye
    Shin, Anna
    Dong, Yaa-Hui
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong-Wook
    Kang, Eun Ha
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study
    A. Shin
    E.H. Park
    Y.-H. Dong
    Y.-J. Ha
    Y.J. Lee
    E.B. Lee
    Y.W. Song
    E.H. Kang
    [J]. Osteoporosis International, 2020, 31 : 2131 - 2139
  • [4] Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study
    Shin, A.
    Park, E. H.
    Dong, Y-H
    Ha, Y-J
    Lee, Y. J.
    Lee, E. B.
    Song, Y. W.
    Kang, E. H.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (11) : 2131 - 2139
  • [5] Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study
    Rotar, Ziga
    Svetina, Petra
    Tomsic, Matija
    Hocevar, Alojzija
    Prapotnik, Sonja
    [J]. BMJ OPEN, 2020, 10 (02):
  • [6] A NATION-WIDE REVIEW OF PATIENTS WITH RHEUMATOID ARTHRITIS IN FINLAND
    Aaltonen, K. J.
    Sokka, T.
    Mottonen, T.
    Korpela, M.
    Komulainen, R.
    Uusitalo, T.
    Salomaa, S.
    Uutela, T.
    Valleala, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 557 - 558
  • [7] Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study
    Se Rim Choi
    Anna Shin
    You-Jung Ha
    Yun Jong Lee
    Eun Bong Lee
    Eun Ha Kang
    [J]. Arthritis Research & Therapy, 25
  • [8] Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study
    Choi, Se Rim
    Shin, Anna
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [9] Biological Agents in Rheumatoid Arthritis and Risk of Malignancy-Results From the Nation-Wide Cohort Study in Japan
    Harigai, Masayoshi
    Nanki, Toshihiro
    Koike, Ryuji
    Tanaka, Michi
    Watanabe, Kaori
    Komano, Yukiko
    Sakai, Ryoko
    Yamazaki, Hayato
    Koike, Takao
    Miyasaka, Nobuyuki
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S41 - S41
  • [10] Is chemoprophylaxis necessary for all latent tuberculosis infection patients receiving IL-17 inhibitors? A cohort study
    Shu, Dan
    Zhang, Zhuying
    Zhou, Eray Yihui
    Ma, Xuzhu
    Zhao, Yi
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (06)
12345